Table 3.
vWf | VEGF | sFlt-1 | Ang-1 | Ang-2 | Tie-2 | |
23 AA subjects | ||||||
VEGF | −0.026, 0.908 | – | – | – | – | – |
sFlt-1 | 0.099, 0.624 | 0.627, 0.001* | – | – | – | – |
Ang-1 | 0.269, 0.215 | 0.505, 0.014* | 0.483, 0.020* | – | – | – |
Ang-2 | 0.209, 0.338 | 0.369, 0.083 | 0.244, 0.263 | 0.245, 0.260 | – | – |
Tie-2 | −0.074, 0.739 | 0.546, 0.007* | 0.526, 0.010* | 0.501, 0.015* | – | – |
56 SCD patients | ||||||
VEGF | 0.120, 0.380 | – | – | – | – | – |
sFlt-1 | 0.114, 0.401 | 0.882, <0.001* | – | – | – | – |
Ang-1 | 0.279, 0.037* | 0.677, <0.001* | 0.610, <0.001* | – | – | – |
Ang-2 | 0.165, 0.225 | 0.645, <0.001* | 0.699, <0.001* | 0.591, <0.001* | – | – |
Tie-2 | 0.317, 0.017 | 0.743, <0.001* | 0.766, <0.001* | 0.743, <0.001* | 0.516, <0.001* | – |
Data presented as Spearman correlation coefficient (r) followed by p values. *p Values <0.05.
Ang-1: angiopoietin-1, Ang-2: angiopoietin-2, Tie-2: the angiopoietin receptor Tie-2, VEGF, vascular endothelial growth factor, sFlt-1, the VEGF receptor Flt-1; vWf, von Willebrand factor.